Path | Description | N | DE | P.DE | FDR |
---|---|---|---|---|---|
path:hsa04020 | Calcium signalling pathway | 240 | 192 | 4.10E−09 | 1.41E−06 |
path:hsa04015 | Rap1 signalling pathway | 210 | 169 | 1.15E−07 | 1.98E−05 |
path:hsa05200 | Pathways in cancer | 531 | 382.8333 | 1.91E−07 | 2.19E−05 |
path:hsa04014 | Ras signalling pathway | 232 | 180 | 2.97E−07 | 2.56E−05 |
path:hsa04010 | MAPK signalling pathway | 294 | 223.33333 | 2.24E−06 | 0.00015382 |
path:hsa04360 | Axon guidance | 182 | 148.5 | 3.46E−06 | 0.00019826 |
path:hsa04072 | Phospholipase D signalling pathway | 148 | 121 | 4.51E−06 | 0.00022149 |
path:hsa04310 | Wnt signalling pathway | 166 | 129.5 | 7.50E−05 | 0.00322397 |
path:hsa04371 | Apelin signalling pathway | 139 | 107.5 | 0.00011119 | 0.00363348 |
path:hsa04724 | Glutamatergic synapse | 114 | 93 | 0.00011675 | 0.00363348 |
path:hsa04390 | Hippo signalling pathway | 157 | 123.5 | 0.00012001 | 0.00363348 |
path:hsa01521 | EGFR tyrosine kinase inhibitor resistance | 79 | 67.5 | 0.00013811 | 0.00363348 |
path:hsa04071 | Sphingolipid signalling pathway | 119 | 94.5 | 0.00013944 | 0.00363348 |
path:hsa05226 | Gastric cancer | 149 | 115.5 | 0.00014787 | 0.00363348 |
path:hsa04550 | Signalling pathways regulating pluripotency of stem cells | 143 | 108.5 | 0.00059275 | 0.01359379 |
path:hsa04151 | PI3K-Akt signalling pathway | 354 | 245 | 0.00076003 | 0.01634056 |
path:hsa05224 | Breast cancer | 147 | 111.5 | 0.00092102 | 0.01863701 |
path:hsa04725 | Cholinergic synapse | 113 | 88 | 0.00148428 | 0.02836619 |
path:hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 53 | 44 | 0.00209794 | 0.03798375 |
path:hsa05225 | Hepatocellular carcinoma | 168 | 123.5 | 0.00284431 | 0.04892215 |